[HTML][HTML] Epidemiology, patient journey and unmet needs related to hemophilia in Brazil: a scoping review with evidence map
NB Schneider, CLP de Araujo, HWG Dos Santos… - … , Transfusion and Cell …, 2024 - Elsevier
… hemophilia (PwH) worldwide. In this scoping review, we aim to investigate the Brazilian
context for hemophilia … profile, (ii) burden of disease and (iii) patient journey and unmet needs. …
context for hemophilia … profile, (ii) burden of disease and (iii) patient journey and unmet needs. …
[PDF][PDF] Clinical-epidemiological profile, burden of disease, and patient journey and unmet needs of hemophilia in Brazil: a scoping review protocol
NB Schneider, CLP de Araujo, M Falavigna - 2022 - osf.io
… brazil[MeSH Terms] OR Brazil OR Brasil … (((hemofilia OR hemofilias OR hemophilia
OR hemophilias OR haemophilia OR haemophilias) OR mh:("Hemofilia A" OR "Hemofilia B")) …
OR hemophilias OR haemophilia OR haemophilias) OR mh:("Hemofilia A" OR "Hemofilia B")) …
[HTML][HTML] Analysis of epidemiological and economic data of hemophilia A patients in Brazil
TTR Sarmento, RM Picoli, M Renni… - J. bras. econ. saúde …, 2022 - pesquisa.bvsalud.org
… To describe the annual medical direct costs per hemophilia A (HA) patient in the Brazilian
public healthcare system (SUS) and to understand and describe the patients' hospital journey, …
public healthcare system (SUS) and to understand and describe the patients' hospital journey, …
Hemophilia in the developing world: successes, frustrations and opportunities
MT PINTO, Z ORTIZ - morbidity and mortality - search.ebscohost.com
… IHTC-Brazil decided to promote ÔLatin America Hemophilia … and to present hemophiliac
patient playing sports and proving … It was a great event that put hemophilia topic in a new light. …
patient playing sports and proving … It was a great event that put hemophilia topic in a new light. …
[HTML][HTML] … EMICIZUMAB VERSUS BYPASSING AGENTS IN PATIENTS WITH HEMOPHILIA A WITH INHIBITORS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM …
P Souza, GR Puopolo, R Leme-Souza - Value in Health, 2019 - valueinhealthjournal.com
… , among patients with hemophilia A with inhibitors (HAwI). The objective of this study was
to evaluate the cost-effectiveness of emicizumab versus BPAs in the Brazilian Public …
to evaluate the cost-effectiveness of emicizumab versus BPAs in the Brazilian Public …
[HTML][HTML] Equity in limit situations: access to treatment for people with hemophilia
ACL Góis, DA Rabelo, TF Marques, NM Sá - Revista Bioética, 2022 - SciELO Brasil
… CF for hemophilia treatment has become widespread and, in Brazil, its adoption depends
on agreements between the State and companies in the sector. Thus, the Brazilian Ministry of …
on agreements between the State and companies in the sector. Thus, the Brazilian Ministry of …
[HTML][HTML] … ANALYSIS OF EMICIZUMAB PROPHYLAXIS FOR HEAMOPHILIA A PATIENTS WITH INHIBITORS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM …
P Souza, GR Puopolo, R Leme-Souza - Value in Health, 2019 - valueinhealthjournal.com
… or at least maintain budget neutrality whilst expanding routine prophylaxis rate among
patients with hemophilia A with inhibitors in Brazilian Public Healthcare System perspective. …
patients with hemophilia A with inhibitors in Brazilian Public Healthcare System perspective. …
EE559 The Economic Impact of Reducing Bleeding With Emicizumab in Patients With Hemophilia A and Factor VIII Inhibitors–Brazilian Case
N Segre, V Mata, TDC Martins - Value in Health, 2022 - valueinhealthjournal.com
… Hemophilia A is an X-linked hereditary bleeding disorder, caused by … from the perspective
of the Brazilian public health system. … sustainability for the public health care Brazilian system. …
of the Brazilian public health system. … sustainability for the public health care Brazilian system. …
[HTML][HTML] … The Cost-Effectiveness of Apcc Vs Rfviia In on-Demand Treatment of Bleeds In Hemophilia A Patients With Inhibitors: A Brazilian Public Health System …
EV Carmo, AO Oladapo, C Rothschild - Value in Health, 2015 - valueinhealthjournal.com
… The development of inhibitors is the most challenging complication of hemophilia treatment.
… rFVIIa in on-demand treatment from the Brazilian public health system perspective. …
… rFVIIa in on-demand treatment from the Brazilian public health system perspective. …
Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries
, … of the World Federation of Hemophilia* - Annals of internal …, 2019 - acpjournals.org
… of hemophilia: 1) The large variability in hemophilia prevalence … of hemophilia at birth (13);
and 3) total number of patients with hemophilia, proportion of patients with severe hemophilia, …
and 3) total number of patients with hemophilia, proportion of patients with severe hemophilia, …
相关搜索
- hemophilia in brazil clinical epidemiological profile
- hemophilia in brazil evidence map
- hemophilia in brazil mortality trends
- delphi panel hemophilia a in brazil
- hemophilia patients with inhibitors
- cost effectiveness patients with hemophilia
- utilization of treatment patients with hemophilia
- routine prophylaxis patients with hemophilia
- pediatric patients with hemophilia
- patients with severe hemophilia
- receiving emicizumab patients with hemophilia
- recombinant factor viii patients with hemophilia
- hemophilia in brazil burden of disease
- hemophilia in brazil scoping review protocol
- hemophilia in brazil causes of death
- patient journey scoping review